Which medication should be avoided in a patient with Parkinson's disease who is on Levodopa?

Which medication should be avoided in a patient with Parkinson's disease who is on Levodopa?

• A. Amantadine
• B. Metoclopramide (Reglan)
• C. Ropinirole
• D. Clozapine

Answer: (B)

Metoclopramide, also known as Reglan, should be avoided in patients with Parkinson's disease who are on Levodopa due to its mechanism of action. Metoclopramide is an antiemetic and prokinetic agent that acts as a dopamine antagonist, specifically blocking dopamine D2 receptors. In patients with Parkinson's disease, who already experience dopamine-related motor symptoms due to a deficiency of dopamine, the use of dopamine antagonists can exacerbate these symptoms and lead to worsening of parkinsonian features. This is particularly important for patients who are being treated with Levodopa, as Levodopa is a precursor to dopamine and is used to replenish the depleted dopamine levels in these patients. Introducing a dopamine antagonist like Metoclopramide can counteract the therapeutic effects of Levodopa and result in increased motor symptoms, such as rigidity and tremors. In contrast, other options like Amantadine, Ropinirole, and Clozapine have different mechanisms of action. Amantadine has dopaminergic properties and can actually help alleviate some of the symptoms of Parkinson's disease. Ropinirole is a dopamine agonist, which mimics the effects of dopamine and can be beneficial for patients with Parkinson's

Metoclopramide, also known as Reglan, should be avoided in patients with Parkinson's disease who are on Levodopa due to its mechanism of action. Metoclopramide is an antiemetic and prokinetic agent that acts as a dopamine antagonist, specifically blocking dopamine D2 receptors. In patients with Parkinson's disease, who already experience dopamine-related motor symptoms due to a deficiency of dopamine, the use of dopamine antagonists can exacerbate these symptoms and lead to worsening of parkinsonian features.

This is particularly important for patients who are being treated with Levodopa, as Levodopa is a precursor to dopamine and is used to replenish the depleted dopamine levels in these patients. Introducing a dopamine antagonist like Metoclopramide can counteract the therapeutic effects of Levodopa and result in increased motor symptoms, such as rigidity and tremors.

In contrast, other options like Amantadine, Ropinirole, and Clozapine have different mechanisms of action. Amantadine has dopaminergic properties and can actually help alleviate some of the symptoms of Parkinson's disease. Ropinirole is a dopamine agonist, which mimics the effects of dopamine and can be beneficial for patients with Parkinson's